Stocktoria
Takeda Pharmaceutical Company Limited 4502.T
JP · Tokyo Stock Exchange · XTKS · stock · Healthcare · website
Takeda Pharmaceutical Company Limited statistics & valuation
Market cap$8.14T
P / S1.8×
P / B1.1×
P / FCF13.0×
Dividend yield3.83%
Net margin-3.4%
Return on equity-2.1%
FCF margin13.9%
Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Gross margin | 65.1% | 65.5% | 66.5% | 69.1% |
| Operating margin | 10.3% | 10.2% | 7.3% | 14.6% |
| Net margin | -3.4% | 2.4% | 3.4% | 7.9% |
| FCF margin | 13.9% | 14.8% | 5.5% | 8.5% |
| Return on assets | -1.0% | 0.8% | 1.0% | 2.3% |
| Return on equity | -2.1% | 1.6% | 2.0% | 5.0% |
| Debt / equity | 0.59× | 0.57× | 0.62× | 0.64× |
| Current ratio | 1.09 | 1.01 | 1.11 | 0.97 |
Source: company filings via Yahoo Finance · JP · as of 2026-03-31. Figures in JPY; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.